A critical discovery in cancer study is occurring with the use of mini-antibodies to reactivate dysfunctional p53. This vital malignant inhibitor protein is frequently inactivated in several forms of tumors, causing https://orangebookmarks.com/story22008050/mini-antibodies-reactivate-tumor-suppressor-p53-the-new-approach-for-tumor-management